Stock listing
NASDAQ:FOLD Amicus Therapeutics Inc Stock
Follow Amicus Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:FOLD
$14.49 USD
Close on Apr 24, 2026 · No longer trades
- Lowest – highest close
- $1.82 – $24.89 USDSince May 31, 2007 · lowest Apr 16, 2014 · highest Dec 22, 2020
Delisted NASDAQ:FOLD no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:FOLD
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Amicus Therapeutics Inc on 6ix
- Calls
- 20 calls with a replay · 20 with a transcript · latest Nov 4, 2025
- Decks
- 109 decks · latest Nov 4, 2025
Events
| Call | When | Status |
|---|---|---|
| Amicus Therapeutics (FOLD) Q3 2025 Earnings Call | Tue, Nov 04, 2025 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q2 2025 Earnings Call | Thu, Jul 31, 2025 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q1 2025 Earnings Call | Thu, May 01, 2025 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q4 2024 Earnings Call | Wed, Feb 19, 2025 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q3 2024 Earnings Call | Wed, Nov 06, 2024 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q2 2024 Earnings Call | Thu, Aug 08, 2024 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q1 2024 Earnings Call | Thu, May 09, 2024 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q4 2023 Earnings Call | Wed, Feb 28, 2024 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q3 2023 Earnings Call | Wed, Nov 08, 2023 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q2 2023 Earnings Call | Tue, Aug 08, 2023 · 8:30 AM ET | Replay |
All 20 calls
| Call | When | Status |
|---|---|---|
| Amicus Therapeutics (FOLD) Q1 2023 Earnings Call | Wed, May 10, 2023 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q4 2022 Earnings Call | Wed, Mar 01, 2023 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q3 2022 Earnings Call | Mon, Nov 07, 2022 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q2 2022 Earnings Call | Thu, Aug 04, 2022 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q1 2022 Earnings Call | Mon, May 09, 2022 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q4 2021 Earnings Call | Thu, Feb 24, 2022 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q3 2021 Earnings Call | Tue, Nov 09, 2021 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q1 2021 Earnings Call | Mon, May 10, 2021 · 8:30 AM ET | Replay |
| Amicus Therapeutics (FOLD) Q4 2020 Earnings Call | Mon, Mar 01, 2021 · 8:30 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2025 Earnings Presentation | Earnings | 26 slides | Nov 4, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 26 slides | Jul 31, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 27 slides | May 1, 2025 |
| FY2024 Earnings Presentation | Earnings | 25 slides | Feb 19, 2025 |
| 43rd Annual J.P. Morgan Healthcare Conference (January 2025) | Conference | 35 slides | Jan 13, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 23 slides | Nov 6, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 23 slides | Aug 8, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 23 slides | May 9, 2024 |
| FY2023 Earnings Presentation | Earnings | 22 slides | Feb 28, 2024 |
| 42nd Annual J.P. Morgan Healthcare Conference (January 2024) | Conference | 31 slides | Jan 8, 2024 |
Show 50 decks
This page holds 50 of 109 decks. Open Decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ted W Love Other companies: Lisata Therapeutics, Inc. (Director · Since at least Sep 17, 2026); Jazz Pharmaceuticals plc (Director · Since at least Dec 1, 2025); Gilead Sciences, Inc. (Director · Since at least Feb 1, 2024); Structure Therapeutics, Inc. (Director · Since at least Aug 3, 2023); Royalty Pharma plc (Director · Since at least Jul 30, 2020); Seagen Inc (Director · Aug 16, 2020 – Dec 14, 2023 · Past); Portola Pharmaceuticals Inc (Director · Sep 18, 2019 – Jul 2, 2020 · Past); Global Blood Therapeutics Inc (President and CEO, Director · Aug 11, 2015 – Oct 5, 2022 · Past); Cascadian Therapeutics Inc (Director · Sep 5, 2013 – Mar 9, 2018 · Past); Savara, Inc. (Director · Sep 5, 2012 – Jun 19, 2013 · Past); Humanigen Inc (Director · Aug 10, 2012 – Jul 10, 2015 · Past); Bio-Rad Laboratories, Inc. (Director · Mar 24, 2010 – Mar 24, 2010 · Past); Onyx Pharmaceuticals Inc (EVP, R&D and Tech. Operations · Feb 1, 2010 – Jul 25, 2012 · Past); Affymax Inc (Director · Dec 14, 2006 – Jun 13, 2012 · Past); Santarus Inc (Director · Jun 7, 2006 – Jan 2, 2014 · Past); Oruka Therapeutics, Inc. (Director · Mar 7, 2006 – Feb 5, 2010 · Past) | Director · Jun 13, 2012 – Jun 4, 2020 · Past |
| James N Topper Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Frazier Lifesciences Acquisition Corp (Chief Executive Officer, Director · Dec 8, 2020 – Dec 11, 2020 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jan 18, 2019 · Past); Aptinyx Inc (Director · Jun 20, 2018 – Mar 31, 2020 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Nov 17, 2020 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – May 18, 2024 · Past); AnaptysBio, Inc. (Director · Jan 25, 2017 – Jan 6, 2023 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Feb 14, 2017 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jun 5, 2013 · Past) | Director · Jun 15, 2010 – Jun 12, 2014 · Past |
| Sol J. Barer Other companies: Teva Pharmaceutical Industries Limited (Director · Since at least Jan 1, 2018); NexImmune, Inc. (Director · Feb 11, 2021 – Jul 5, 2023 · Past); Avalo Therapeutics, Inc. (Director · Feb 3, 2020 – Jun 15, 2021 · Past); PDS Biotechnology Corporation (Director · Sep 30, 2015 – Mar 15, 2019 · Past); CervoMed Inc. (Director · Nov 1, 2013 – Jul 24, 2014 · Past); Aevi Genomic Medicine LLC (Director · Jun 30, 2012 – Feb 3, 2020 · Past); InspireMD Inc. (Director · Jul 11, 2011 – Dec 7, 2016 · Past); Aegerion Pharmaceuticals Inc (Director · May 1, 2011 – Nov 29, 2016 · Past); Celgene Corporation (Director · Dec 31, 2005 – Jan 13, 2011 · Past) | Director · Jan 6, 2009 – Jun 9, 2016 · Past |
| Michael A. Kelly Other companies: Prime Medicine, Inc. (Board Member · Since at least Oct 19, 2022); DMC Global Inc. (Director · Since at least Jul 24, 2020); NeoGenomics, Inc. (Board Member · Since at least Jul 15, 2020); Aprea Therapeutics, Inc. (Director · Sep 28, 2020 – Jun 30, 2021 · Past); Hookipa Pharma Inc (Director · Apr 17, 2019 – Jun 30, 2022 · Past) | Director · Since at least Dec 1, 2020 |
| Craig A Wheeler Other companies: Apellis Pharmaceuticals, Inc. (Director · Since at least Apr 17, 2025); Momenta Pharmaceuticals Inc (President & CEO, Director · Aug 22, 2006 – Sep 10, 2020 · Past); Avanir Pharmaceuticals Inc (Director · Feb 13, 2006 – Feb 12, 2014 · Past) | Director · Since at least Jun 9, 2016 |
| Donald J Hayden Jr Other companies: Theseus Pharmaceuticals Inc (Director · May 17, 2022 – Feb 14, 2024 · Past); Insmed Incorporated (Director · Nov 14, 2017 – Apr 9, 2019 · Past); Regenxbio Inc. (Director · Oct 11, 2017 – May 29, 2020 · Past) | Director · Jan 2, 2018 – Jun 7, 2018 · Past |
| Lynn Dorsey Bleil Other companies: Stericycle Inc (Director · May 27, 2015 – Nov 4, 2024 · Past); DST Systems Inc (Director · May 13, 2014 – Apr 16, 2018 · Past); Auspex Pharmaceuticals Inc (Director · May 6, 2014 – May 5, 2015 · Past) | Director · Since at least Sep 7, 2018 |
| Margaret G McGlynn Other companies: Novavax, Inc. (Director · Since at least Dec 7, 2020); Vertex Pharmaceuticals Incorporated (Director · May 12, 2011 – May 1, 2023 · Past); Air Products and Chemicals, Inc. (Director · Dec 31, 2005 – Sep 30, 2020 · Past) | Director · Since at least Oct 28, 2009 |
| Daphne Quimi Other companies: Century Therapeutics, Inc. (Director · Since at least Oct 1, 2022); Amylyx Pharmaceuticals, Inc. (Director · Since at least Jan 6, 2022) | Chief Financial Officer · Oct 1, 2020 – Jan 17, 2023 · Past |
| Eiry W. Roberts Other companies: Bausch Health Companies Inc. (Director · Since at least May 19, 2026); Neurocrine Biosciences, Inc. (Chief Medical Officer · Since at least Dec 6, 2023) | Director · Since at least Jun 6, 2024 |
All 24 people
| Person | Seat |
|---|---|
| Glenn P. Sblendorio Other companies: Mineralys Therapeutics, Inc. (Chairman · Since at least Feb 19, 2026); 4D Molecular Therapeutics, Inc. (Board Member · Since at least Jan 5, 2026) | Director · Since at least Jun 5, 2025 |
| John F Crowley Other companies: Entrada Therapeutics, Inc. (Director · Oct 28, 2021 – Jun 8, 2023 · Past); Intellia Therapeutics, Inc. (Director · Oct 2, 2020 – Jun 14, 2023 · Past) | Executive Chairman, Director · Dec 31, 2011 – Mar 1, 2024 · Past |
| Michael Raab Other companies: Tempest Therapeutics, Inc. (Director · Since at least Jun 25, 2021); Ardelyx, Inc. (President & CEO, Director · Since at least Jan 19, 2017) | Director · Since at least Jun 9, 2016 |
| Pol F. Boudes Other companies: Protalix BioTherapeutics, Inc. (de) (Director · Since at least Jan 1, 2020); Galectin Therapeutics Inc. (Chief Medical Officer · Mar 2, 2020 – Jan 24, 2024 · Past) | Chief Medical Officer · Jun 15, 2010 – Jun 4, 2012 · Past |
| Burke W. Whitman Other companies: Omega Healthcare Investors, Inc. (Director · Since at least Oct 1, 2020) | Director · Since at least Oct 1, 2020 |
| Orlov S Nicole Schaeffer Other companies: Insmed Incorporated (Chief People Strategy Officer · Since at least Jun 2, 2014) | SVP, HR & Leadership Devt · Feb 3, 2009 – Feb 15, 2012 · Past |
| Robert Essner Other companies: Organon & Co. (Director · Since at least Jun 2, 2021) | Director · Jun 10, 2021 – Jun 10, 2021 · Past |
| Bradley L Campbell | President and CEO, Director · Since at least Nov 2, 2020 |
| David Michael Clark | Chief People Officer · Since at least Dec 18, 2023 |
| Jeff Castelli | Chief Development Officer · Since at least Dec 18, 2023 |
| Julie Yu | VP Clinical Ops & Data Mgmt · Dec 2, 2013 – Jun 15, 2015 · Past |
| Karin Ludwig | Senior VP, Clinical Research · May 30, 2007 – May 30, 2007 · Past |
| Kenneth Peist | VP, Legal & IP · Jan 3, 2011 – Jan 4, 2016 · Past |
| Simon N R Harford | Chief Financial Officer · Since at least Aug 21, 2025 |
Log in to ask 6ix AI your own questions about Amicus Therapeutics Inc.